4.8 Article

Bioactive Metal-Organic Frameworks with Specific Metal-Nitrogen (M-N) Active Sites for Efficient Sonodynamic Tumor Therapy

期刊

ACS NANO
卷 15, 期 12, 页码 20003-20012

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsnano.1c07547

关键词

zif-8; zinc-nitrogen; reactive oxygen species; ligand to metal charge transfer; sonodynamic therapy

资金

  1. National Natural Science Foundation of China [21822802, 51772018, 22102070]
  2. National Basic Research Program of China [2016YFA0201500]
  3. Fundamental Research Funds for the Central Universities [buctrc201915, XK1802-8]

向作者/读者索取更多资源

The combination of bioactivity and sonodynamic properties of zeolite imidazolium framework-8 nanocrystals is discovered for efficient tumor therapy, with high tumor inhibition efficiency demonstrated in vivo experiments. This study expands the application of metal-organic frameworks (MOFs) and contributes to a better understanding of the mechanism of action of sonosensitizers.
Sonodynamic therapy (SDT) offers an efficient noninvasive strategy for cancer treatment. However, the efficiency of SDT is limited by the structural and physicochemical properties of ultrasound (US)-sensitive agents. Here, we discover the combination of bioactivity and sonodynamic properties of zeolite imidazolium framework-8 nanocrystals (ZIF-8 NCs) for efficient tumor therapy. ZIF-8 NCs are susceptible to biodegradation to release zinc ions (Zn2+) triggered by the weakly acidic tumor microenvironment, demonstrating the bioactivity to induce apoptosis in cancer cells. Density functional theory calculations combined with experiments revealed that the unsaturated zinc-nitrogen (Zn-N) active sites on the surface of ZIF-8 NCs allow an enhanced electron transfer via ligand to metal charge transfer bands from the highest occupied molecular orbitals to the lowest unoccupied molecular orbitals. This process is critical for the generation of reactive oxygen species by metal-organic frameworks (MOFs) under US irradiation. In vivo experiments show that ZIF-8 NCs exhibit high tumor inhibition efficiency (84.6%) as both a bioactive anticancer agent and a sonosensitizer. We believe that this study can expand the application of MOFs and contribute to a better understanding of the mechanism of action of sonosensitizers.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据